KP
About
Krishna Polu is based out of and is the CEO, President and Co-Founder of R1 Therapeutics. Lupus Research Alliance as a Steering Committee Member. Krishna Polu attended Stanford University.
Position in the VCSift Database
- • 3 investors hold the CEO, Co-Founder & President role in VCSift. Krishna Polu is one of them.
- • 1,751 investors are based in California, United States.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
- Location
- California, US
Contact Information
linkedin.com/in/••••••••
Find more investors like Krishna
Search Investors